All posts by Vishal Dalwadi

Ipca Laboratories Limited: Value Pick Stock April 2020

3rd April 2020

Ipca Laboratories Limited (IPCA) is a fully-integrated Indian pharmaceutical company manufacturing and marketing over 350 formulations and 80 Active Pharmaceutical Ingredients (APIs) covering various therapeutic segments. Ipca Laboratories Limited: Profile Ipca Laboratories was founded by a group of businessmen and medical professionals in the year 1949 under the name of The Indian Pharmaceutical Combine Association Limited. The name of the organization was changed to Ipca Laboratories Ltd

By Vishal Dalwadi

No Comment

Key Points from the Reserve Bank of India Policy: March 2020

27th March 2020

The Reserve Bank of India (RBI) on March 27, 2020, used the majority of orthodox methods to fight COVID-19-led economic issues. The Reserve Bank has significantly reduced interest rates across the board, taking cues from other central banks of the world, as part of emergency measures to safeguard the economy from the coronavirus. Take a Look at Measures - Sizeable Cut in Repo Rate: The Reserve Bank of India announced a massive 75 basis points rate cut in Repo Rate, bringing it to 4.40%

By Vishal Dalwadi

No Comment

Prince Pipes and Fittings Limited IPO – Review, Listing

30th December 2019

Update: Prince Pipes and Fittings: Listing One of the prominent Polymer Pipes and Fittings manufacturers in India, Prince Pipes Limited had a weak debut with a 10 percent discount to its IPO price. The stock opened at INR 160 on the National Stock Exchange and Bombay Stock Exchange, against the issue price of INR 178 per share. The Stock made a high of INR 177.90 and a low of INR 152.50 before it ended at INR 166.90 on the NSE when the market closed. In terms of volumes, Prince Pipes

By Vishal Dalwadi

No Comment

Ujjivan Small Finance Bank Ltd IPO: Review, Listing

12th December 2019

Update: Ujjivan Small Finance Bank: Listing Ujjivan Small Finance Bank, the subsidiary company of microfinance lender Ujjivan Financial Services Limited started its very first trade at INR 58 on the Bombay Stock Exchange on 12 December 2019. The stock listed with a premium of 56.75 percent over the issue price of INR 37 per share. The Stock made a high of INR 62.80 and a low of INR 53.05 before it ended at INR 55.95 on the National Stock Exchange when the market closed, which is up by 51.22

By Vishal Dalwadi

No Comment

CSB Bank Limited IPO: Review, Listing

4th December 2019

Update: CSB Bank Limited Listing CSB Bank Limited (Catholic Syrian Bank), made a strong debut on bourse on 4 December, with the share price rallying 57.4% over the IPO price of INR 195 on the listing day. Kerala-based private sector bank started off the first day at INR 275 on the BSE, a 41% premium over its issue price of INR 195 per share and touched an intraday high of INR 307. Must Read: Value Pick Stock APL APOLLO TUBES LTD 19 November, 2019 CSB Bank

By Vishal Dalwadi

No Comment

News

How to Reduce Home Loan EMI

12th November 2019

Two of the key parameters to consider while opting for home loans are the rate of interest and the tenure of the loan. Basis these two components and the principal amount, the EMI can be calculated. EMI is the equitable monthly payment that you need to make for the loans that you have opted for. This amount takes into account both the interest and a principal component. However, for many home loan borrowers, a major chunk of their salary or profits goes towards this EMI payment. Therefore, here

By Vishal Dalwadi

No Comment

Metropolis Healthcare Limited: Value Pick Stock July 2019, Update

11th November 2019

Update: Q2 FY 2019-20 Numbers Metropolis Healthcare Limited, a complete chain of diagnostic companies with its central laboratory in Mumbai, Maharashtra has posted its Q2 FY 2019-20 numbers today. Read standalone details - Revenue from operations stood at INR 172.28 crore in September 2019 up 16.61 percent Y-O-Y basis from INR 147.74 crore in September 2018. Q-O-Q revenues grew by 9.77 percent (INR 156.95 crore for June 2019) Quarterly Net Profit at INR 31.68 crore in September 2019 up 72.87

By Vishal Dalwadi

No Comment

VALUE PICK MAY ’18: GMM Pfaudler Limited, Update

7th November 2019

Update: Q2 FY 2019-20 Numbers GMM Pfaudler Limited - a leading supplier of engineered equipment and systems for critical applications in the global chemical and pharmaceutical markets has presented its quarter 2 numbers today during the market hours. Here are key points - Revenue from operations stood at INR 136.09 Cr in September '19 up 37.22% Y-O-Y from INR 99.18 Cr in September '18. However, the quarter-on-quarter revenue grew by 4.49% (INR 130.25 Cr for June '19) Quarterly Net Profit at

By Vishal Dalwadi

No Comment